Implantica AG (publ) announced the addition of Amit Kukreja in the position of Chief Market Access & Strategygy Officer. Amit brings 15 years of extensive global medtech industry and strategy experience to Implantica. He has served in several worldwide and regional leadership and advisory roles, driving and shaping reimbursement, health economics, clinical evidence planning, payer relations and upstream marketing & communications for disruptive medtech products. Amit will head worldwide market access and grow commercial adoption for Implantica's extensive product pipeline of advanced medical technologies. Most recently, Amit served as the Vice President of Corporate Market Access at Masimo Corporation, a global leader in innovative noninvasive patient monitoring technologies, where he was responsible for developing and executing the company's market access strategies. Before that, he was the Vice President of Global Marketing, Reimbursement & Patient Access at Second Sight Medical Products, a global leader in neuromodulation implant devices for blindness. During his previous roles at Second Sight, as Global Vice President of Market Access and EMEA Director of Market Access, Amit created and expanded reimbursement and funding pathways for the world's first FDA & CE mark cleared artificial vision implant system across North America, EMEA, and APAC regions.